Your browser version may not work well with NCBI's Web applications. More information here...
1: Crit Care. 2005;9(6):R755-63. Epub 2005 Nov 9.
Related Articles, Links
Click here to read Click here to read
Comment in:
Early veno-venous haemodiafiltration for sepsis-related multiple organ failure.

Page B, Vieillard-Baron A, Chergui K, Peyrouset O, Rabiller A, Beauchet A, Aegerter P, Jardin F.

Medical Intensive Care Unit, University Hospital Ambroise Paré, Assistance Publique Hôpitaux de Paris, 9 avenue Charles de Gaulle, 92104 Boulogne, France.

INTRODUCTION: We conducted a prospective observational study from January 1995 to December 2004 to evaluate the impact on recovery of a major advance in renal replacement therapy, namely continuous veno-venous haemodiafiltration (CVVHDF), in patients with refractory septic shock. METHOD: CVVHDF was implemented after 6-12 hours of maximal haemodynamic support, and base excess monitoring was used to evaluate the improvement achieved. Of the 60 patients studied, 40 had improved metabolic acidosis after 12 hours of CVVHDF, with a progressive improvement in all failing organs; the final mortality rate in this subgroup was 30%. In contrast, metabolic acidosis did not improve in the remaining 20 patients after 12 hours of CVVHDF, and the mortality rate in this subgroup was 100%. The crude mortality rate for the whole group was 53%, which is significantly lower than the predicted mortality using Simplified Acute Physiology Score II (79%). CONCLUSION: Early CVVHDF may improve the prognosis of sepsis-related multiple organ failure. Failure to correct metabolic acidosis rapidly during the procedure was a strong predictor of mortality.

Publication Types:
PMID: 16356224 [PubMed - indexed for MEDLINE]

PMCID: PMC1414012